About Andover House Inc: https://andoverhouse.org/
Andover House, Inc. (ANHI) is a not-for-profit scholarly journal publisher focusing on the online dissemination of academic journals that are open to the scientific community and accessible to the public without additional charges to readers and libraries.
Founded in January 2018, ANHI is registered in the Commonwealth of Massachusetts (AG#064695) and with the IRS as a 501(3)c public charity (EIN 82-4239886; on Amazon Smile: andoverhouseinc).
The aim and scope of ANHI are to provide good quality and supportive publishing forum with a quick turnaround time for nanomedicine researchers and offer a cutting-edge and reliable information source to authors, societies, libraries, and the interested public without any additional cost.
Our objective is to publish peer-reviewed scientific reports and individual articles online in academic journals that are open to the scientific community and accessible by the public without additional charge to readers and libraries. Presently we publish one scholarly journal, Precision Nanomedicine (E-ISSN:2639-9431), which is indexed in SCOPUS.
Our mission is to further the progress of science, engineering, and technology in medicine and to promote all progressive and rational aspects of nanomedicine from basic science through commercialization while exercising good publishing practice. We support authors who wish to qualify their manuscripts deposited early in preprint servers such as bioRxiv or arXiv, other not peer-reviewed research, e.g., presented at conferences, published as a thesis, or have previously appeared in other “non-journal” venues (for example, blogs or posters).
All articles receive a unique digital object identifier (DOI) and are archived in Portico for preservation. DOI-s can also be searched in Crossref and DOAJ. We are members of COPE (The Committee on Publication Ethics), DOAJ (The Directory of Open Access Journals), and FJN, The Free Journal Network. Our green archiving policy is registered in Sherpa/Romeo, so both preprint and post-print PDFs (as well as Publisher’s versions) can be archived without restrictions. Authors are responsible for updating the archived preprint with the journal reference (including DOI) and a link to the published articles on the appropriate journal website upon publication.
The Publisher is governed by the Board of Directors, which oversees operations, approves the annual budget, and sets strategic goals for the organization. We are endorsed by the European Foundation for Clinical Nanomedicine and the International Society for Nanomedicine https://clinam.org; by the European Society for Nanomedicine https://esnam.org, collaborate with NanoMedNorth https://nanomednorth.com, recommended by the "Nano2Clinic Cancer Nanomedicine - from the bench to the bedside” COST Action https://www.nano2clinic.eu/news/publishing-your-work-precision-nanomedicine and by the British Society for Nanomedicine https://www.britishsocietynanomedicine.org/links/.
NOTE: ANHI is a signatory of DORA, the San Francisco Declaration on Research Assessment. Accordingly, we advise against the use of journal-based metrics, such as Journal Impact Factors, as a surrogate measure of individual research articles’ quality to assess an individual scientist’s contributions or in hiring, promotion, or funding decisions. We support article-based metrics and follow the publication policies of WHO, COPE, and ICMJE, The International Committee of Medical Journal Editors.